Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001209191-23-059032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-18 | 2023-12-14 | RXRX | Dar Zavain | Dir | S - Sale | $9.00 | -20.1K | 53.8K | -27% | -$181.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-14 | S | D | 20,141 | $9.00 | 53,823 | D | — | — |